Renaissance Technologies - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 44 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$76,000
-74.8%
19,461
-68.9%
0.00%
Q3 2021$302,000
-53.7%
62,520
-38.7%
0.00%
-100.0%
Q2 2021$652,000
-44.8%
101,970
-45.8%
0.00%0.0%
Q1 2021$1,182,000
-3.0%
188,161
+6.4%
0.00%0.0%
Q4 2020$1,219,000
+1039.3%
176,861
+420.8%
0.00%
Q4 2019$107,000
-94.3%
33,961
-85.4%
0.00%
-100.0%
Q2 2018$1,868,0000.0%232,0980.0%0.00%
-50.0%
Q1 2018$1,868,000232,0980.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders